By Username
Enter a URL of an MRSS feed

Amgen Videos by Popular

Amgen Biotech Experience

The Amgen Foundation today announced 2.5 million in new grants for the Amgen Biotech Experience, an innovative science education program, ...

T-Mobile Offers 200 MB of Free iPad Data.

T-Mobile, Apple, iPad Air, iPad, Verizon, ATT, Spring, Amgen, Heineken, Europe, Africa, Asian, Ebay, Amazon, IRS, Taxes.

Stocks Held Back By Plunge In Factory Orders

The stock market is inching higher in early trading as a plunge in factory orders last month made investors cautious.

Stocks Edge Higher

Stocks on Wall Street rose slightly after data showed a steep drop in orders for long-lasting manufactured goods last month.

Deals Send Stocks Edging Higher On Wall Street

A handful of corporate deals helped nudge the stock market higher despite a disappointing report on the economy.

US Stocks Sag Following Kerry Remarks

The stock market sagged in afternoon trading after Secretary of State John Kerry ratcheted up pressure against Syria.

Stocks tick higher despite weak durable goods data

08/26/13 Stocks ticked higher Monday, with the Dow edging above the psychologically-important 15,000 mark, but weaker-than-expected durable ...

Stocks dip, lose early momentum on durable goods data

08/26/13 Stocks ticked higher Monday, then dipped to close out in the red, on weaker-than-expected durable goods orders.

Latest Business News: Aug 25th, 7pm

The United States Department of Agriculture often trumpets the numbers of jobs that are expected to result from loans. Whether these jobs ... tags: AmgenandHealthcareLONDONPat_GelsingerPedro_NicolaciRecovery

Amgen Said To Be Near A Deal To Buy Onyx

The biotech giant Amgen near a deal to buy Onyx Pharmaceuticals, a maker of cancer-fighting drugs, for about 125 a share. If a transaction ... tags: Acquisitions_and_DivestituresAmgenAmgen_IncDrugHealthcareMergers_AcquisitionsOnyx_Grand_Prix

Amgen close to Onyx takeover, deal possible within week-sources

Onyx Pharmaceuticals is close to selling itself to larger rival Amgen after the cancer drugmaker's high stock price discouraged other ... tags: AmgenBusinessHealthinIncindustryNews